Chronic obstructive pulmonary disease and sacubitril: explore the role of neprilysin before its inhibition

Adv Respir Med. 2018;86(5):255-256. doi: 10.5603/ARM.2018.0041.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aminobutyrates / therapeutic use*
  • Angiotensin Receptor Antagonists / therapeutic use*
  • Biphenyl Compounds
  • Drug Combinations
  • Drug Therapy, Combination
  • Humans
  • Neprilysin / therapeutic use*
  • Pulmonary Disease, Chronic Obstructive / therapy*
  • Renin-Angiotensin System / drug effects
  • Tetrazoles / therapeutic use*
  • Valsartan

Substances

  • Aminobutyrates
  • Angiotensin Receptor Antagonists
  • Biphenyl Compounds
  • Drug Combinations
  • Tetrazoles
  • Valsartan
  • Neprilysin
  • sacubitril and valsartan sodium hydrate drug combination